KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Teva Pharmaceutical Industries (TEVA) Debt Ratio (2016 - 2025)

Historic Debt Ratio for Teva Pharmaceutical Industries (TEVA) over the last 17 years, with Q4 2025 value amounting to 0.41.

  • Teva Pharmaceutical Industries' Debt Ratio fell 879.2% to 0.41 in Q4 2025 from the same period last year, while for Dec 2025 it was 0.41, marking a year-over-year decrease of 879.2%. This contributed to the annual value of 0.41 for FY2025, which is 879.2% down from last year.
  • Teva Pharmaceutical Industries' Debt Ratio amounted to 0.41 in Q4 2025, which was down 879.2% from 0.42 recorded in Q3 2025.
  • Teva Pharmaceutical Industries' Debt Ratio's 5-year high stood at 0.51 during Q2 2021, with a 5-year trough of 0.41 in Q4 2025.
  • Moreover, its 5-year median value for Debt Ratio was 0.48 (2023), whereas its average is 0.47.
  • Per our database at Business Quant, Teva Pharmaceutical Industries' Debt Ratio skyrocketed by 807.32% in 2021 and then plummeted by 879.2% in 2025.
  • Over the past 5 years, Teva Pharmaceutical Industries' Debt Ratio (Quarter) stood at 0.48 in 2021, then dropped by 0.3% to 0.48 in 2022, then decreased by 5.36% to 0.46 in 2023, then fell by 0.87% to 0.45 in 2024, then fell by 8.79% to 0.41 in 2025.
  • Its Debt Ratio stands at 0.41 for Q4 2025, versus 0.42 for Q3 2025 and 0.43 for Q2 2025.